Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9187 |
High Similarity |
NPD422 |
Phase 1 |
0.8561 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8551 |
High Similarity |
NPD3750 |
Approved |
0.8527 |
High Similarity |
NPD3225 |
Approved |
0.8462 |
Intermediate Similarity |
NPD2797 |
Approved |
0.8421 |
Intermediate Similarity |
NPD3268 |
Approved |
0.837 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.837 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8284 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8271 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.8231 |
Intermediate Similarity |
NPD9717 |
Approved |
0.8188 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8143 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8129 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8112 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8056 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8056 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8045 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8045 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8029 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8028 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7973 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7958 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7958 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7951 |
Intermediate Similarity |
NPD9697 |
Approved |
0.7943 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7943 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7929 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7914 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7883 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7879 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7872 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7832 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7829 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7823 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7801 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7801 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.777 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7763 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7761 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7748 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7748 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7746 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7742 |
Intermediate Similarity |
NPD3134 |
Approved |
0.774 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7712 |
Intermediate Similarity |
NPD3749 |
Approved |
0.771 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7687 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7676 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7656 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7635 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7632 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7626 |
Intermediate Similarity |
NPD411 |
Approved |
0.7622 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7612 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7597 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7589 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7584 |
Intermediate Similarity |
NPD920 |
Approved |
0.7582 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7556 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7551 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.755 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.754 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7537 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7532 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7532 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7518 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7482 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7482 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7468 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7468 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7466 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7465 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7464 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD1934 |
Approved |
0.745 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7429 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7419 |
Intermediate Similarity |
NPD940 |
Approved |
0.7419 |
Intermediate Similarity |
NPD846 |
Approved |
0.7413 |
Intermediate Similarity |
NPD6651 |
Approved |
0.741 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7376 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7372 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7343 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7343 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7333 |
Intermediate Similarity |
NPD17 |
Approved |
0.7333 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7329 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7329 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7301 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.729 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7284 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7284 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7267 |
Intermediate Similarity |
NPD7837 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7259 |
Intermediate Similarity |
NPD5585 |
Approved |
0.7255 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7222 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7218 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7215 |
Intermediate Similarity |
NPD919 |
Approved |
0.7211 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.72 |
Intermediate Similarity |
NPD6666 |
Approved |
0.72 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7183 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7183 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7163 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7162 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7152 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6362 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7132 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7132 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7132 |
Intermediate Similarity |
NPD290 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7124 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7111 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7099 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7095 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7092 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7091 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7091 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7077 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7077 |
Intermediate Similarity |
NPD74 |
Approved |
0.7077 |
Intermediate Similarity |
NPD9266 |
Approved |
0.7067 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7059 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7054 |
Intermediate Similarity |
NPD968 |
Approved |
0.7048 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7042 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7027 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7023 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD2354 |
Approved |
0.702 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7019 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7014 |
Intermediate Similarity |
NPD1048 |
Approved |
0.7007 |
Intermediate Similarity |
NPD4978 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7006
|
Intermediate Similarity |
NPD7808 |
Phase 3 |